Drug recall D-0133-2025
Product
Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-443-20
Reason for recall
Subpotent and Superpotent Drug
Lots and codes
Lot #: 3115893, Exp. Date 6/2025
Recall details
- Recalling firm
- Mylan Institutional, Inc., Rockford, IL
- Quantity
- 1,664 cartons
- Distribution
- Nationwide in the USA.
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 19, 2024
Related products
- Levothyroxine Sodium – drug information
- NDC 51079-442 Levothyroxine Sodium · Levothyroxine Sodium 100 ug/1 · Mylan Institutional Inc.
- NDC 51079-445 Levothyroxine Sodium · Levothyroxine Sodium 150 ug/1 · Mylan Institutional Inc.
- NDC 51079-444 Levothyroxine Sodium · Levothyroxine Sodium 25 ug/1 · Mylan Institutional Inc.
- NDC 51079-440 Levothyroxine Sodium · Levothyroxine Sodium 50 ug/1 · Mylan Institutional Inc.
- NDC 51079-441 Levothyroxine Sodium · Levothyroxine Sodium 75 ug/1 · Mylan Institutional Inc.
- NDC 51079-443 Levothyroxine Sodium · Levothyroxine Sodium 125 ug/1 · Mylan Institutional Inc.